(function(){var loadHandler=window['sl_{DC1F7540-1882-43D0-A075-6AAB30A2CE8C}'];loadHandler&&loadHandler(3, '<div id="spr0_5dc05728"><div id="spr1_5dc05728" class="kern slide"><img id="img4_5dc05728" src="data/img1.png" width="720px" height="540px" alt="" style="left:0px;top:0px;"/></div><div id="spr2_5dc05728" class="kern slide"><img id="img0_5dc05728" src="data/img2.png" width="721.48" height="100.8" alt="" style="left:-1.48px;"/><div id="svg1_5dc05728" style="left:-1.48px;top:99.523px;"><svg width="722" height="4" viewBox="0 0 722 4"><path fill="#c76c02" d="M0,0 h721.48 v3.6 h-721.48 Z"/></svg></div><div id="svg2_5dc05728" style="left:-1.48px;top:0.523px;"><svg width="722" height="4" viewBox="0 0 722 4"><path fill="#2e3546" d="M0,0 h721.48 v3.6 h-721.48 Z"/></svg></div><img id="img1_5dc05728" src="data/img3.png" width="721.48" height="43.101" alt="" style="top:496.899px;"/><div id="spr3_5dc05728" style="left:657.715px;top:499.855px;"><img id="img2_5dc05728" src="data/img4.png" width="56" height="36" alt="CHRC logo_with text.psd" style="left:-0.105px;top:-0.177px;"/></div><div id="spr4_5dc05728" style="left:6.874px;top:23.136px;"><div style="width:0px;"><span id="txt0_5dc05728" data-width="642.884766" style="left:38.687px;top:5.272px;">FOURIER: LDL-C Reduction with Evolocumab</span></div></div><div id="spr5_5dc05728" style="left:13.757px;top:504.073px;"><div style="width:0px;"><span id="txt1_5dc05728" class="nokern" data-width="240.846680" style="left:7.2px;top:9.471px;">Sabatine MS et al; Â Lancet Diabetes Endocrinol. 2017 Dec;5(12):941-950.</span></div></div><div id="spr6_5dc05728" style="left:0.74px;top:123.936px;"><img id="img3_5dc05728" src="data/img7.png" width="720" height="341" alt="A close up of a map  Description automatically generated" style="top:-0.22px;"/></div></div></div>');})();